Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells

Qingdi Quentin Li, Gangduo Wang, Furong Huang, Malathi Banda, Eddie Reed

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Objectives β-Elemene, a natural compound extracted from over 50 different Chinese medicinal herbs and plants, has been effective in the treatment of hyperplastic and proliferative disorders such as prostatic hypertrophy, hysteromyoma and neoplasms. Our previous studies have demonstrated that β-elemene exhibits strong inhibitory activity in ovarian cancer cells. The aim of the present study was to assess the effect of β-elemene on prostate cancer cells as well as other types of tumour cells and to determine whether the effect of β-elemene on prostate cancer cell death was mediated through the induction of apoptosis. Methods The MTT assay was used to evaluate the ability of β-elemene to inhibit cellular proliferation in cancer cells. Cellular apoptosis was assessed by annexin V binding, TUNEL and ELISA-based assays. Caspase activity was measured using a caspases assay kit. The protein levels of Bcl-2, caspases, cytochrome c and poly(ADP-ribose) polymerase (PARP) were analysed by Western blotting. Key findings Here, we showed that β-elemene had an antiproliferative effect on androgen-insensitive prostate carcinoma DU145 and PC-3 cells. Treatment with β-elemene also inhibited the growth of brain, breast, cervical, colon and lung carcinoma cells. The effect of β-elemene on cancer cells was dose dependent, with IC50 values ranging from 47 to 95 μg/ml (230-465 μ m). TUNEL assay and flow cytometric analysis using annxin V/propidium iodide staining revealed that the percentage of apoptotic prostate cancer cells was increased by β-elemene in a dose- and time-dependent manner. Moreover, β-elemene exposure resulted in a decreased Bcl-2 protein level, increased cytochrome c release, and activated PARP and caspase-3, -7, -9, and -10 in prostate cancer cells. Conclusions Overall, these findings suggest that β-elemene exerts broad-spectrum antitumour activity against many types of solid carcinoma and supports a proposal of β-elemene as a new potentially therapeutic drug for castration-resistant prostate cancer and other solid tumours.

Original languageEnglish (US)
Pages (from-to)1018-1027
Number of pages10
JournalJournal of Pharmacy and Pharmacology
Volume62
Issue number8
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Antineoplastic Agents
Prostatic Neoplasms
Neoplasms
Poly(ADP-ribose) Polymerases
In Situ Nick-End Labeling
Medicinal Plants
Caspases
Cytochromes c
Carcinoma
elemene
Caspase 2
Apoptosis
Caspase 7
Propidium
Annexin A5
Castration
Prostatic Hyperplasia
Caspase 3
Ovarian Neoplasms
Androgens

Keywords

  • β-elemene
  • apoptosis
  • caspases
  • Chinese medicine
  • natural product
  • prostate cancer

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells. / Li, Qingdi Quentin; Wang, Gangduo; Huang, Furong; Banda, Malathi; Reed, Eddie.

In: Journal of Pharmacy and Pharmacology, Vol. 62, No. 8, 08.2010, p. 1018-1027.

Research output: Contribution to journalArticle

Li, Qingdi Quentin ; Wang, Gangduo ; Huang, Furong ; Banda, Malathi ; Reed, Eddie. / Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells. In: Journal of Pharmacy and Pharmacology. 2010 ; Vol. 62, No. 8. pp. 1018-1027.
@article{2fa388ce99b74574b8f6a29ad4e10d15,
title = "Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells",
abstract = "Objectives β-Elemene, a natural compound extracted from over 50 different Chinese medicinal herbs and plants, has been effective in the treatment of hyperplastic and proliferative disorders such as prostatic hypertrophy, hysteromyoma and neoplasms. Our previous studies have demonstrated that β-elemene exhibits strong inhibitory activity in ovarian cancer cells. The aim of the present study was to assess the effect of β-elemene on prostate cancer cells as well as other types of tumour cells and to determine whether the effect of β-elemene on prostate cancer cell death was mediated through the induction of apoptosis. Methods The MTT assay was used to evaluate the ability of β-elemene to inhibit cellular proliferation in cancer cells. Cellular apoptosis was assessed by annexin V binding, TUNEL and ELISA-based assays. Caspase activity was measured using a caspases assay kit. The protein levels of Bcl-2, caspases, cytochrome c and poly(ADP-ribose) polymerase (PARP) were analysed by Western blotting. Key findings Here, we showed that β-elemene had an antiproliferative effect on androgen-insensitive prostate carcinoma DU145 and PC-3 cells. Treatment with β-elemene also inhibited the growth of brain, breast, cervical, colon and lung carcinoma cells. The effect of β-elemene on cancer cells was dose dependent, with IC50 values ranging from 47 to 95 μg/ml (230-465 μ m). TUNEL assay and flow cytometric analysis using annxin V/propidium iodide staining revealed that the percentage of apoptotic prostate cancer cells was increased by β-elemene in a dose- and time-dependent manner. Moreover, β-elemene exposure resulted in a decreased Bcl-2 protein level, increased cytochrome c release, and activated PARP and caspase-3, -7, -9, and -10 in prostate cancer cells. Conclusions Overall, these findings suggest that β-elemene exerts broad-spectrum antitumour activity against many types of solid carcinoma and supports a proposal of β-elemene as a new potentially therapeutic drug for castration-resistant prostate cancer and other solid tumours.",
keywords = "β-elemene, apoptosis, caspases, Chinese medicine, natural product, prostate cancer",
author = "Li, {Qingdi Quentin} and Gangduo Wang and Furong Huang and Malathi Banda and Eddie Reed",
year = "2010",
month = "8",
doi = "10.1111/j.2042-7158.2010.01135.x",
language = "English (US)",
volume = "62",
pages = "1018--1027",
journal = "Journal of Pharmacy and Pharmacology",
issn = "0022-3573",
publisher = "Pharmaceutical Press",
number = "8",

}

TY - JOUR

T1 - Antineoplastic effect of β-elemene on prostate cancer cells and other types of solid tumour cells

AU - Li, Qingdi Quentin

AU - Wang, Gangduo

AU - Huang, Furong

AU - Banda, Malathi

AU - Reed, Eddie

PY - 2010/8

Y1 - 2010/8

N2 - Objectives β-Elemene, a natural compound extracted from over 50 different Chinese medicinal herbs and plants, has been effective in the treatment of hyperplastic and proliferative disorders such as prostatic hypertrophy, hysteromyoma and neoplasms. Our previous studies have demonstrated that β-elemene exhibits strong inhibitory activity in ovarian cancer cells. The aim of the present study was to assess the effect of β-elemene on prostate cancer cells as well as other types of tumour cells and to determine whether the effect of β-elemene on prostate cancer cell death was mediated through the induction of apoptosis. Methods The MTT assay was used to evaluate the ability of β-elemene to inhibit cellular proliferation in cancer cells. Cellular apoptosis was assessed by annexin V binding, TUNEL and ELISA-based assays. Caspase activity was measured using a caspases assay kit. The protein levels of Bcl-2, caspases, cytochrome c and poly(ADP-ribose) polymerase (PARP) were analysed by Western blotting. Key findings Here, we showed that β-elemene had an antiproliferative effect on androgen-insensitive prostate carcinoma DU145 and PC-3 cells. Treatment with β-elemene also inhibited the growth of brain, breast, cervical, colon and lung carcinoma cells. The effect of β-elemene on cancer cells was dose dependent, with IC50 values ranging from 47 to 95 μg/ml (230-465 μ m). TUNEL assay and flow cytometric analysis using annxin V/propidium iodide staining revealed that the percentage of apoptotic prostate cancer cells was increased by β-elemene in a dose- and time-dependent manner. Moreover, β-elemene exposure resulted in a decreased Bcl-2 protein level, increased cytochrome c release, and activated PARP and caspase-3, -7, -9, and -10 in prostate cancer cells. Conclusions Overall, these findings suggest that β-elemene exerts broad-spectrum antitumour activity against many types of solid carcinoma and supports a proposal of β-elemene as a new potentially therapeutic drug for castration-resistant prostate cancer and other solid tumours.

AB - Objectives β-Elemene, a natural compound extracted from over 50 different Chinese medicinal herbs and plants, has been effective in the treatment of hyperplastic and proliferative disorders such as prostatic hypertrophy, hysteromyoma and neoplasms. Our previous studies have demonstrated that β-elemene exhibits strong inhibitory activity in ovarian cancer cells. The aim of the present study was to assess the effect of β-elemene on prostate cancer cells as well as other types of tumour cells and to determine whether the effect of β-elemene on prostate cancer cell death was mediated through the induction of apoptosis. Methods The MTT assay was used to evaluate the ability of β-elemene to inhibit cellular proliferation in cancer cells. Cellular apoptosis was assessed by annexin V binding, TUNEL and ELISA-based assays. Caspase activity was measured using a caspases assay kit. The protein levels of Bcl-2, caspases, cytochrome c and poly(ADP-ribose) polymerase (PARP) were analysed by Western blotting. Key findings Here, we showed that β-elemene had an antiproliferative effect on androgen-insensitive prostate carcinoma DU145 and PC-3 cells. Treatment with β-elemene also inhibited the growth of brain, breast, cervical, colon and lung carcinoma cells. The effect of β-elemene on cancer cells was dose dependent, with IC50 values ranging from 47 to 95 μg/ml (230-465 μ m). TUNEL assay and flow cytometric analysis using annxin V/propidium iodide staining revealed that the percentage of apoptotic prostate cancer cells was increased by β-elemene in a dose- and time-dependent manner. Moreover, β-elemene exposure resulted in a decreased Bcl-2 protein level, increased cytochrome c release, and activated PARP and caspase-3, -7, -9, and -10 in prostate cancer cells. Conclusions Overall, these findings suggest that β-elemene exerts broad-spectrum antitumour activity against many types of solid carcinoma and supports a proposal of β-elemene as a new potentially therapeutic drug for castration-resistant prostate cancer and other solid tumours.

KW - β-elemene

KW - apoptosis

KW - caspases

KW - Chinese medicine

KW - natural product

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=77954936163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954936163&partnerID=8YFLogxK

U2 - 10.1111/j.2042-7158.2010.01135.x

DO - 10.1111/j.2042-7158.2010.01135.x

M3 - Article

VL - 62

SP - 1018

EP - 1027

JO - Journal of Pharmacy and Pharmacology

JF - Journal of Pharmacy and Pharmacology

SN - 0022-3573

IS - 8

ER -